Methods and dosage forms for the treatment of human cancers

a technology for human cancer and daily dosage, applied in the direction of biocide, plant/algae/fungi/lichens, drug compositions, etc., can solve the problems of poor cellular repair mechanism, increased risk, and cancer as a leading cause of death worldwide, and achieve the effect of improving the symptoms of cancer patients

Inactive Publication Date: 2012-05-03
LIFE PLUS MICHIGAN
View PDF15 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Metastases are the major cause of death from cancer.
Cancer is a leading cause of death worldwide.
The overall risk accumulation is combined with the tendency for cellular repair mechanisms to be less effective as a person grows older.
Cervical cancer, which is caused by HPV, is a leading cause of cancer death among women in low-income countries.
In high-income countries, tobacco use, alcohol use, and being overweight or obese are major risk factors for cancer.
All of these techniques have significant drawbacks in terms of side effects and patient discomfort.
This can result in pain, diarrhea, constipation, mouth sores, hair loss, nausea, and vomiting.
However, the immune system does not always recognize cancer cells as “foreign.” Also, cancer may develop when the immune system breaks down or does not function adequately.
Despite the immense amount of worldwide research and efforts to stem the tide of cancer and its side effects, the disease in its many manifestations continues to be a huge problem.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0043]In preferred forms, the invention involves the administration of a dosage form prepared using plant parts of Arum palaestinum Boiss, which grows naturally in the Middle East, and particularly in Palestine and adjoining regions. This plant is of the genus Arum, family Araceae, subfamily Aroideae, and tribe Areae, and has a Nomen No. of 4357. The name was verified on Nov. 5, 1985 by ARS Systematic Botanists. The species priority site is the Ornamental Plant Germplasm Center. The plant is also known by common names, including Black Calla and Solomon's-Lily.

Analysis of Arum palaestinum Boiss

[0044]A detailed examination designed to determine the identity of the chemical components of Arum palaestinum Boiss was undertaken using Gas Chromatography-Mass Spectroscopy (GC-MS). In particular, one gram of dried plant leaf was boiled in 100 ml of dichloromethane for approximately 30 minutes. After cooling, the liquid was filtered, followed by solvent evaporation under nitrogen to a final v...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
timeaaaaaaaaaa
volumeaaaaaaaaaa
volumesaaaaaaaaaa
Login to view more

Abstract

Methods for the treatment of human cancers, daily dosage forms for cancer patients, and methods of formulating the dosage forms are provided wherein the daily dosage form contains from about 10-6,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. Preferably, the dosage forms are formulated by first creating an aqueous decoction of Arum palaestinum Boiss, followed by fortification of the decoction with additional quantities of β-sitosterol, isovanillin, and linolenic acid.

Description

CROSS-REFERENCE TO RELATED APPLICATION[0001]This is a continuation of identically-titled U.S. patent application Ser. No. 12 / 905,847, filed Oct. 15, 2010, which is incorporated herein by reference in its entirety.BACKGROUND OF THE INVENTION[0002]1. Field of the Invention[0003]The present invention is directed to methods for the treatment of human cancers, daily dosage forms for administration to cancer patients, and methods of formulating such dosage forms. More particularly, the invention is concerned with the administration of daily dosage forms (e.g., aqueous mixtures, capsules, pills, or tablets) containing from about 10-6,000 mg of each of β-sitosterol, isovanillin, and linolenic acid. Such treatment provides a marked decline and / or elimination of cancerous tumors, particularly those of the bladder, breast, liver, and lung, and a corresponding enhancement of the wellness and lifestyles of the treated patients.[0004]2. Description of the Prior Art[0005]Cancer is a generic term f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K31/56A61P35/00
CPCA61K31/11A61K31/202A61K31/575A61K36/888A61K2300/00A61P35/00
Inventor ZAID, GENE H.BURGOYNE, THOMAS W.WOLF, BETH ANN
Owner LIFE PLUS MICHIGAN
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products